Keros Therapeutics Inc.

NASDAQ: KROS · Real-Time Price · USD
14.46
0.04 (0.28%)
At close: Aug 15, 2025, 3:59 PM
14.08
-2.66%
After-hours: Aug 15, 2025, 05:42 PM EDT

Keros Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-3.16 -7.65 -11.58 -23.24
PEG Ratio
0.82 -0.3 -0.18 1.66
PS Ratio
166.94 7.75K n/a 67.92
PB Ratio
1.04 3.52 4.37 5.61
P/FCF Ratio
-3.64 -9.22 -17 -21.61
P/OCF Ratio
-3.68 -9.4 -17.3 -21.97
OCF/S Ratio
-45.32 -824.56 n/a -3.09
Debt / Equity Ratio
0.03 0.04 0.05 0.00
Quick Ratio
21.45 14.25 17.32 20.97
Current Ratio
21.45 14.25 17.27 21.23
Asset Turnover
0.01 0.00 n/a 0.08
Interest Coverage
n/a n/a -114.79K -14.09K
Return on Equity
-0.33 -0.46 -0.38 -0.24
Return on Assets
-0.3 -0.41 -0.34 -0.23
Return on Invested Capital
-0.36 -0.49 -0.39 -0.24
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 -4.4 n/a 0.96
Net Profit Margin
-52.78 -1.01K n/a -2.92
Pretax Profit Margin
-52.69 -1.01K n/a -2.82
Operating Profit Margin
-59.39 -1.13K n/a -2.8
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-52.34 -1.01K n/a -2.8